<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-01-01" modified="2020-10-07" version="212">
<accession>P13612</accession>
<accession>D3DPG4</accession>
<accession>Q7Z4L6</accession>
<name>ITA4_HUMAN</name>
<protein>
<recommendedName>
<fullName>Integrin alpha-4</fullName>
</recommendedName>
<alternativeName>
<fullName>CD49 antigen-like family member D</fullName>
</alternativeName>
<alternativeName>
<fullName>Integrin alpha-IV</fullName>
</alternativeName>
<alternativeName>
<fullName>VLA-4 subunit alpha</fullName>
</alternativeName>
<cdAntigenName>CD49d</cdAntigenName>
</protein>
<gene>
<name type="primary">ITGA4</name>
<name type="synonym">CD49D</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="EMBO J." volume="8" first="1361" last="1368">
<title>The primary structure of the alpha 4 subunit of VLA-4: homology to other integrins and a possible cell-cell adhesion function.</title>
<authorList>
<person name="Takada Y."/>
<person name="Elices M.J."/>
<person name="Crouse C."/>
<person name="Hemler M.E."/>
</authorList>
<dbReference type="PubMed" id="2788572"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1989.tb03516.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="Eur. J. Immunol." volume="22" first="1099" last="1102">
<title>A single mRNA encodes the alpha 150 and alpha 80/70 forms of the alpha subunit of VLA4.</title>
<authorList>
<person name="Rubio M."/>
<person name="Nueda A."/>
<person name="Vara A."/>
<person name="Corbi-Lopez A.L."/>
</authorList>
<dbReference type="PubMed" id="1551405"/>
<dbReference type="DOI" id="10.1002/eji.1830220434"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="Mol. Immunol." volume="32" first="1453" last="1454">
<title>Identification of two variants of the human integrin alpha 4 subunit.</title>
<authorList>
<person name="Szabo M.C."/>
<person name="McIntyre B.W."/>
</authorList>
<dbReference type="PubMed" id="8643114"/>
<dbReference type="DOI" id="10.1016/0161-5890(96)00001-6"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT GLN-878</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT GLN-878</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="4094" last="4098">
<title>Characterization of the alpha 4 integrin gene promoter.</title>
<authorList>
<person name="Rosen G.D."/>
<person name="Birkenmeier T.M."/>
<person name="Dean D.C."/>
</authorList>
<dbReference type="PubMed" id="2034655"/>
<dbReference type="DOI" id="10.1073/pnas.88.10.4094"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-87 (ISOFORM 1)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1987" name="Proc. Natl. Acad. Sci. U.S.A." volume="84" first="3239" last="3243">
<title>The very late antigen family of heterodimers is part of a superfamily of molecules involved in adhesion and embryogenesis.</title>
<authorList>
<person name="Takada Y."/>
<person name="Strominger J.L."/>
<person name="Hemler M.E."/>
</authorList>
<dbReference type="PubMed" id="3033641"/>
<dbReference type="DOI" id="10.1073/pnas.84.10.3239"/>
</citation>
<scope>PROTEIN SEQUENCE OF 34-47</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="1786" last="1791">
<title>Functional and structural analysis of VLA-4 integrin alpha 4 subunit cleavage.</title>
<authorList>
<person name="Teixido J."/>
<person name="Parker C.M."/>
<person name="Kassner P.D."/>
<person name="Hemler M.E."/>
</authorList>
<dbReference type="PubMed" id="1730718"/>
</citation>
<scope>PROTEIN SEQUENCE OF 592-601</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>MUTAGENESIS OF LYS-590 AND ARG-591</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="5955" last="5962">
<title>A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion.</title>
<authorList>
<person name="Iida J."/>
<person name="Meijne A.M.L."/>
<person name="Oegema T.R. Jr."/>
<person name="Yednock T.A."/>
<person name="Kovach N.L."/>
<person name="Furcht L.T."/>
<person name="McCarthy J.B."/>
</authorList>
<dbReference type="PubMed" id="9488735"/>
<dbReference type="DOI" id="10.1074/jbc.273.10.5955"/>
</citation>
<scope>DOMAIN</scope>
<scope>INTERACTION WITH CSPG4</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Nature" volume="402" first="676" last="681">
<title>Binding of paxillin to alpha4 integrins modifies integrin-dependent biological responses.</title>
<authorList>
<person name="Liu S."/>
<person name="Thomas S.M."/>
<person name="Woodside D.G."/>
<person name="Rose D.M."/>
<person name="Kiosses W.B."/>
<person name="Pfaff M."/>
<person name="Ginsberg M.H."/>
</authorList>
<dbReference type="PubMed" id="10604475"/>
<dbReference type="DOI" id="10.1038/45264"/>
</citation>
<scope>INTERACTION WITH PXN; LPXN AND TGFB1I1</scope>
<scope>MUTAGENESIS OF TYR-1024</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="40903" last="40909">
<title>Phosphorylation of the integrin alpha 4 cytoplasmic domain regulates paxillin binding.</title>
<authorList>
<person name="Han J."/>
<person name="Liu S."/>
<person name="Rose D.M."/>
<person name="Schlaepfer D.D."/>
<person name="McDonald H."/>
<person name="Ginsberg M.H."/>
</authorList>
<dbReference type="PubMed" id="11533025"/>
<dbReference type="DOI" id="10.1074/jbc.m102665200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-1021</scope>
<scope>MUTAGENESIS OF SER-1021</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="J. Cell Sci." volume="117" first="5405" last="5415">
<title>alpha4beta1- and alpha6beta1-integrins are functional receptors for midkine, a heparin-binding growth factor.</title>
<authorList>
<person name="Muramatsu H."/>
<person name="Zou P."/>
<person name="Suzuki H."/>
<person name="Oda Y."/>
<person name="Chen G.Y."/>
<person name="Sakaguchi N."/>
<person name="Sakuma S."/>
<person name="Maeda N."/>
<person name="Noda M."/>
<person name="Takada Y."/>
<person name="Muramatsu T."/>
</authorList>
<dbReference type="PubMed" id="15466886"/>
<dbReference type="DOI" id="10.1242/jcs.01423"/>
</citation>
<scope>INTERACTION WITH MDK</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="26107" last="26115">
<title>Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner.</title>
<authorList>
<person name="Saegusa J."/>
<person name="Akakura N."/>
<person name="Wu C.Y."/>
<person name="Hoogland C."/>
<person name="Ma Z."/>
<person name="Lam K.S."/>
<person name="Liu F.T."/>
<person name="Takada Y.K."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="18635536"/>
<dbReference type="DOI" id="10.1074/jbc.m804835200"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF THR-222 AND GLY-223</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="J. Cell Biol." volume="183" first="1159" last="1173">
<title>JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis by alpha4beta1 integrin activation.</title>
<authorList>
<person name="Luissint A.C."/>
<person name="Lutz P.G."/>
<person name="Calderwood D.A."/>
<person name="Couraud P.O."/>
<person name="Bourdoulous S."/>
</authorList>
<dbReference type="PubMed" id="19064666"/>
<dbReference type="DOI" id="10.1083/jcb.200805061"/>
</citation>
<scope>FUNCTION IN LEUKOCYTE TO ENDOTHELIAL CELLS ADHESION</scope>
<scope>INTERACTION WITH JAML</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Nat. Biotechnol." volume="27" first="378" last="386">
<title>Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.</title>
<authorList>
<person name="Wollscheid B."/>
<person name="Bausch-Fluck D."/>
<person name="Henderson C."/>
<person name="O'Brien R."/>
<person name="Bibel M."/>
<person name="Schiess R."/>
<person name="Aebersold R."/>
<person name="Watts J.D."/>
</authorList>
<dbReference type="PubMed" id="19349973"/>
<dbReference type="DOI" id="10.1038/nbt.1532"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-480; ASN-518; ASN-538 AND ASN-645</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1021</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2012" name="J. Immunol." volume="189" first="5809" last="5819">
<title>Integrins alphavbeta3 and alpha4beta1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1.</title>
<authorList>
<person name="Fujita M."/>
<person name="Takada Y.K."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="23125415"/>
<dbReference type="DOI" id="10.4049/jimmunol.1200889"/>
</citation>
<scope>FUNCTION</scope>
<scope>BINDING TO CX3CL1</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH CX3CR1 AND CX3CL1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1021</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="259" last="271">
<title>Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins alphavbeta3, alpha4beta1, and alpha5beta1.</title>
<authorList>
<person name="Fujita M."/>
<person name="Zhu K."/>
<person name="Fujita C.K."/>
<person name="Zhao M."/>
<person name="Lam K.S."/>
<person name="Kurth M.J."/>
<person name="Takada Y.K."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="25398877"/>
<dbReference type="DOI" id="10.1074/jbc.m114.579946"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<comment type="function">
<text evidence="12 13 15 16">Integrins alpha-4/beta-1 (VLA-4) and alpha-4/beta-7 are receptors for fibronectin. They recognize one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. They are also receptors for VCAM1. Integrin alpha-4/beta-1 recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha-4/beta-7 is also a receptor for MADCAM1. It recognizes the sequence L-D-T in MADCAM1. On activated endothelial cells integrin VLA-4 triggers homotypic aggregation for most VLA-4-positive leukocyte cell lines. It may also participate in cytolytic T-cell interactions with target cells. ITGA4:ITGB1 binds to fractalkine (CX3CL1) and may act as its coreceptor in CX3CR1-dependent fractalkine signaling (PubMed:23125415). ITGA4:ITGB1 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (PubMed:18635536, PubMed:25398877).</text>
</comment>
<comment type="subunit">
<text evidence="8 10 13 15 19">Heterodimer of an alpha and a beta subunit. The alpha subunit can sometimes be cleaved into two non-covalently associated fragments. Alpha-4 associates with either beta-1 or beta-7. Alpha-4 interacts with PXN, LPXN, and TGFB1I1/HIC5. Interacts with CSPG4 through CSPG4 chondroitin sulfate glycosaminoglycan. Interacts with JAML; integrin alpha-4/beta-1 may regulate leukocyte to endothelial cells adhesion by controlling JAML homodimerization. ITGA4:ITGB1 is found in a ternary complex with CX3CR1 and CX3CL1 (PubMed:23125415). Interacts with MDK (PubMed:15466886). ITGA4:ITGB1 interacts with MDK; this interaction mediates MDK-induced osteoblast cells migration through PXN phosphorylation (PubMed:15466886).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703044">
<id>P13612</id>
</interactant>
<interactant intactId="EBI-7358775">
<id>Q8IZP0-2</id>
<label>ABI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703044">
<id>P13612</id>
</interactant>
<interactant intactId="EBI-703066">
<id>P05556</id>
<label>ITGB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703044">
<id>P13612</id>
</interactant>
<interactant intactId="EBI-702932">
<id>P26010</id>
<label>ITGB7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703044">
<id>P13612</id>
</interactant>
<interactant intactId="EBI-702209">
<id>P49023</id>
<label>PXN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703044">
<id>P13612</id>
</interactant>
<interactant intactId="EBI-1051449">
<id>O43294</id>
<label>TGFB1I1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703044">
<id>P13612</id>
</interactant>
<interactant intactId="EBI-297693">
<id>P84092</id>
<label>Ap2m1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P13612-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P13612-2</id>
<name>2</name>
<sequence type="described" ref="VSP_056612 VSP_056613"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="19">The SG1 motif is involved in binding to chondroitin sulfate glycosaminoglycan and cell adhesion.</text>
</comment>
<comment type="PTM">
<text evidence="9">Phosphorylation on Ser-1027 inhibits PXN binding.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the integrin alpha chain family.</text>
</comment>
<comment type="sequence caution" evidence="22">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAB59613" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="22">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="CAA34852" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="X16983">
<property type="protein sequence ID" value="CAA34852.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L12002">
<property type="protein sequence ID" value="AAB59613.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC020595">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471058">
<property type="protein sequence ID" value="EAX10985.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471058">
<property type="protein sequence ID" value="EAX10987.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC055419">
<property type="protein sequence ID" value="AAH55419.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS42788.1">
<molecule id="P13612-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS82540.1">
<molecule id="P13612-2"/>
</dbReference>
<dbReference type="PIR" id="S06046">
<property type="entry name" value="S06046"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000876.3">
<molecule id="P13612-1"/>
<property type="nucleotide sequence ID" value="NM_000885.5"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001303241.1">
<molecule id="P13612-2"/>
<property type="nucleotide sequence ID" value="NM_001316312.1"/>
</dbReference>
<dbReference type="PDB" id="3V4P">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.15"/>
<property type="chains" value="A/C=34-620"/>
</dbReference>
<dbReference type="PDB" id="3V4V">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/C=34-620"/>
</dbReference>
<dbReference type="PDB" id="4HKC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="B=1003-1032"/>
</dbReference>
<dbReference type="PDB" id="5C7Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.77"/>
<property type="chains" value="B=1008-1015"/>
</dbReference>
<dbReference type="PDB" id="5FPI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.77"/>
<property type="chains" value="B=1008-1015"/>
</dbReference>
<dbReference type="PDBsum" id="3V4P"/>
<dbReference type="PDBsum" id="3V4V"/>
<dbReference type="PDBsum" id="4HKC"/>
<dbReference type="PDBsum" id="5C7Z"/>
<dbReference type="PDBsum" id="5FPI"/>
<dbReference type="BMRB" id="P13612"/>
<dbReference type="SMR" id="P13612"/>
<dbReference type="BioGRID" id="109883">
<property type="interactions" value="518"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1802">
<property type="entry name" value="Integrin alpha4-beta1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1823">
<property type="entry name" value="Integrin alpha4-beta7 complex"/>
</dbReference>
<dbReference type="CORUM" id="P13612"/>
<dbReference type="DIP" id="DIP-34971N"/>
<dbReference type="IntAct" id="P13612">
<property type="interactions" value="29"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000380227"/>
<dbReference type="BindingDB" id="P13612"/>
<dbReference type="ChEMBL" id="CHEMBL278"/>
<dbReference type="DrugBank" id="DB04997">
<property type="generic name" value="ATL1102"/>
</dbReference>
<dbReference type="DrugBank" id="DB05092">
<property type="generic name" value="CDP323"/>
</dbReference>
<dbReference type="DrugBank" id="DB00108">
<property type="generic name" value="Natalizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB05122">
<property type="generic name" value="R1295"/>
</dbReference>
<dbReference type="DrugBank" id="DB05468">
<property type="generic name" value="R411"/>
</dbReference>
<dbReference type="DrugBank" id="DB06822">
<property type="generic name" value="Tinzaparin"/>
</dbReference>
<dbReference type="DrugBank" id="DB09033">
<property type="generic name" value="Vedolizumab"/>
</dbReference>
<dbReference type="DrugCentral" id="P13612"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2443"/>
<dbReference type="GlyGen" id="P13612">
<property type="glycosylation" value="12 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P13612"/>
<dbReference type="PhosphoSitePlus" id="P13612"/>
<dbReference type="BioMuta" id="ITGA4"/>
<dbReference type="DMDM" id="311033436"/>
<dbReference type="EPD" id="P13612"/>
<dbReference type="jPOST" id="P13612"/>
<dbReference type="MassIVE" id="P13612"/>
<dbReference type="MaxQB" id="P13612"/>
<dbReference type="PaxDb" id="P13612"/>
<dbReference type="PeptideAtlas" id="P13612"/>
<dbReference type="PRIDE" id="P13612"/>
<dbReference type="ProteomicsDB" id="52943">
<molecule id="P13612-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="69208"/>
<dbReference type="ABCD" id="P13612">
<property type="antibodies" value="17 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="10886">
<property type="antibodies" value="1973 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3676"/>
<dbReference type="Ensembl" id="ENST00000339307">
<molecule id="P13612-2"/>
<property type="protein sequence ID" value="ENSP00000340149"/>
<property type="gene ID" value="ENSG00000115232"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000397033">
<molecule id="P13612-1"/>
<property type="protein sequence ID" value="ENSP00000380227"/>
<property type="gene ID" value="ENSG00000115232"/>
</dbReference>
<dbReference type="GeneID" id="3676"/>
<dbReference type="KEGG" id="hsa:3676"/>
<dbReference type="UCSC" id="uc002unu.4">
<molecule id="P13612-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3676"/>
<dbReference type="DisGeNET" id="3676"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000115232.13"/>
<dbReference type="GeneCards" id="ITGA4"/>
<dbReference type="HGNC" id="HGNC:6140">
<property type="gene designation" value="ITGA4"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000115232">
<property type="expression patterns" value="Tissue enhanced (blood, lymphoid tissue)"/>
</dbReference>
<dbReference type="MIM" id="192975">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P13612"/>
<dbReference type="OpenTargets" id="ENSG00000115232"/>
<dbReference type="PharmGKB" id="PA29940"/>
<dbReference type="eggNOG" id="KOG3637">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000158443"/>
<dbReference type="HOGENOM" id="CLU_1639373_0_0_1"/>
<dbReference type="InParanoid" id="P13612"/>
<dbReference type="KO" id="K06483"/>
<dbReference type="OMA" id="CSVGYIY"/>
<dbReference type="OrthoDB" id="189377at2759"/>
<dbReference type="PhylomeDB" id="P13612"/>
<dbReference type="TreeFam" id="TF105391"/>
<dbReference type="PathwayCommons" id="P13612"/>
<dbReference type="Reactome" id="R-HSA-198933">
<property type="pathway name" value="Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202733">
<property type="pathway name" value="Cell surface interactions at the vascular wall"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-216083">
<property type="pathway name" value="Integrin cell surface interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8949275">
<property type="pathway name" value="RUNX3 Regulates Immune Response and Cell Migration"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9679191">
<property type="pathway name" value="Potential therapeutics for SARS"/>
</dbReference>
<dbReference type="SignaLink" id="P13612"/>
<dbReference type="SIGNOR" id="P13612"/>
<dbReference type="BioGRID-ORCS" id="3676">
<property type="hits" value="21 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ITGA4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="CD49d"/>
<dbReference type="GenomeRNAi" id="3676"/>
<dbReference type="Pharos" id="P13612">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P13612"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="P13612">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115232">
<property type="expression patterns" value="Expressed in monocyte and 145 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P13612">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P13612">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030426">
<property type="term" value="C:growth cone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034668">
<property type="term" value="C:integrin alpha4-beta1 complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034669">
<property type="term" value="C:integrin alpha4-beta7 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050839">
<property type="term" value="F:cell adhesion molecule binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015026">
<property type="term" value="F:coreceptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001968">
<property type="term" value="F:fibronectin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005178">
<property type="term" value="F:integrin binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:1990405">
<property type="term" value="F:protein antigen binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060385">
<property type="term" value="P:axonogenesis involved in innervation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030183">
<property type="term" value="P:B cell differentiation"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0140039">
<property type="term" value="P:cell-cell adhesion in response to extracellular stimulus"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033631">
<property type="term" value="P:cell-cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007160">
<property type="term" value="P:cell-matrix adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003366">
<property type="term" value="P:cell-matrix adhesion involved in ameboidal cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904646">
<property type="term" value="P:cellular response to amyloid-beta"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071345">
<property type="term" value="P:cellular response to cytokine stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990771">
<property type="term" value="P:clathrin-dependent extracellular exosome endocytosis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050904">
<property type="term" value="P:diapedesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035987">
<property type="term" value="P:endodermal cell differentiation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030198">
<property type="term" value="P:extracellular matrix organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034113">
<property type="term" value="P:heterotypic cell-cell adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098657">
<property type="term" value="P:import into cell"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007229">
<property type="term" value="P:integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007159">
<property type="term" value="P:leukocyte cell-cell adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050901">
<property type="term" value="P:leukocyte tethering or rolling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090074">
<property type="term" value="P:negative regulation of protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990138">
<property type="term" value="P:neuron projection extension"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000353">
<property type="term" value="P:positive regulation of endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903238">
<property type="term" value="P:positive regulation of leukocyte tethering or rolling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000406">
<property type="term" value="P:positive regulation of T cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1905564">
<property type="term" value="P:positive regulation of vascular endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043113">
<property type="term" value="P:receptor clustering"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050776">
<property type="term" value="P:regulation of immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034446">
<property type="term" value="P:substrate adhesion-dependent cell spreading"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.130.10.130">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00615"/>
<dbReference type="InterPro" id="IPR013517">
<property type="entry name" value="FG-GAP"/>
</dbReference>
<dbReference type="InterPro" id="IPR013519">
<property type="entry name" value="Int_alpha_beta-p"/>
</dbReference>
<dbReference type="InterPro" id="IPR000413">
<property type="entry name" value="Integrin_alpha"/>
</dbReference>
<dbReference type="InterPro" id="IPR013649">
<property type="entry name" value="Integrin_alpha-2"/>
</dbReference>
<dbReference type="InterPro" id="IPR018184">
<property type="entry name" value="Integrin_alpha_C_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR028994">
<property type="entry name" value="Integrin_alpha_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR032695">
<property type="entry name" value="Integrin_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF01839">
<property type="entry name" value="FG-GAP"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF08441">
<property type="entry name" value="Integrin_alpha2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01185">
<property type="entry name" value="INTEGRINA"/>
</dbReference>
<dbReference type="SMART" id="SM00191">
<property type="entry name" value="Int_alpha"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF69179">
<property type="entry name" value="SSF69179"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS51470">
<property type="entry name" value="FG_GAP"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="PROSITE" id="PS00242">
<property type="entry name" value="INTEGRIN_ALPHA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0130">Cell adhesion</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0401">Integrin</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="17">
<location>
<begin position="1"/>
<end position="33"/>
</location>
</feature>
<feature type="chain" description="Integrin alpha-4" id="PRO_0000016244">
<location>
<begin position="34"/>
<end position="1032"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="6">
<location>
<begin position="35"/>
<end position="977"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="978"/>
<end position="1001"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="6">
<location>
<begin position="1002"/>
<end position="1032"/>
</location>
</feature>
<feature type="repeat" description="FG-GAP 1" evidence="7">
<location>
<begin position="35"/>
<end position="100"/>
</location>
</feature>
<feature type="repeat" description="FG-GAP 2" evidence="7">
<location>
<begin position="110"/>
<end position="177"/>
</location>
</feature>
<feature type="repeat" description="FG-GAP 3" evidence="7">
<location>
<begin position="185"/>
<end position="237"/>
</location>
</feature>
<feature type="repeat" description="FG-GAP 4" evidence="7">
<location>
<begin position="238"/>
<end position="291"/>
</location>
</feature>
<feature type="repeat" description="FG-GAP 5" evidence="7">
<location>
<begin position="292"/>
<end position="351"/>
</location>
</feature>
<feature type="repeat" description="FG-GAP 6" evidence="7">
<location>
<begin position="355"/>
<end position="412"/>
</location>
</feature>
<feature type="repeat" description="FG-GAP 7" evidence="7">
<location>
<begin position="416"/>
<end position="478"/>
</location>
</feature>
<feature type="calcium-binding region" evidence="6">
<location>
<begin position="314"/>
<end position="322"/>
</location>
</feature>
<feature type="calcium-binding region" evidence="6">
<location>
<begin position="377"/>
<end position="385"/>
</location>
</feature>
<feature type="calcium-binding region" evidence="6">
<location>
<begin position="439"/>
<end position="447"/>
</location>
</feature>
<feature type="short sequence motif" description="SG1">
<location>
<begin position="606"/>
<end position="616"/>
</location>
</feature>
<feature type="short sequence motif" description="GFFKR motif">
<location>
<begin position="1003"/>
<end position="1007"/>
</location>
</feature>
<feature type="site" description="Cleavage">
<location>
<begin position="591"/>
<end position="592"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 9">
<location>
<position position="1021"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="79"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="138"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="229"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="480"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="518"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="538"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="626"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="645"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="660"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="806"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="821"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="91"/>
<end position="101"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="144"/>
<end position="165"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="183"/>
<end position="198"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="486"/>
<end position="495"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="501"/>
<end position="557"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="622"/>
<end position="627"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="698"/>
<end position="711"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="852"/>
<end position="890"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="897"/>
<end position="902"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056612" evidence="21">
<original>DYVKKFGENF</original>
<variation>GSISKYRART</variation>
<location>
<begin position="186"/>
<end position="195"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056613" evidence="21">
<location>
<begin position="196"/>
<end position="1032"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35322532." id="VAR_047423">
<original>S</original>
<variation>T</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1143675." id="VAR_047424">
<original>V</original>
<variation>A</variation>
<location>
<position position="824"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1143676." id="VAR_003978" evidence="18 20">
<original>R</original>
<variation>Q</variation>
<location>
<position position="878"/>
</location>
</feature>
<feature type="mutagenesis site" description="Blocks binding to PLA2G2A." evidence="12">
<original>T</original>
<variation>A</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="mutagenesis site" description="Blocks binding to PLA2G2A." evidence="12">
<original>G</original>
<variation>A</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes almost completely cleavage." evidence="11">
<original>K</original>
<variation>Q</variation>
<location>
<position position="590"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes completely cleavage." evidence="11">
<original>R</original>
<variation>L</variation>
<location>
<position position="591"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="9">
<original>S</original>
<variation>A</variation>
<location>
<position position="1021"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces PXN binding." evidence="9">
<original>S</original>
<variation>D</variation>
<location>
<position position="1021"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts PXN binding." evidence="8">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1024"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="42"/>
<end position="45"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="54"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="64"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="87"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="102"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="127"/>
<end position="133"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="141"/>
<end position="145"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="152"/>
<end position="156"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="165"/>
<end position="168"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="174"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="178"/>
<end position="180"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="193"/>
<end position="197"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="202"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="208"/>
<end position="215"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="218"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="223"/>
<end position="229"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="230"/>
<end position="233"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="234"/>
<end position="237"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="253"/>
<end position="258"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="267"/>
<end position="272"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="275"/>
<end position="277"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="280"/>
<end position="286"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="288"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="308"/>
<end position="313"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="318"/>
<end position="320"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="322"/>
<end position="327"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="332"/>
<end position="334"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="338"/>
<end position="344"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="346"/>
<end position="349"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="351"/>
<end position="353"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="381"/>
<end position="383"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="386"/>
<end position="390"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="393"/>
<end position="396"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="398"/>
<end position="403"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="415"/>
<end position="419"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="420"/>
<end position="422"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="429"/>
<end position="438"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="440"/>
<end position="445"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="447"/>
<end position="452"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="453"/>
<end position="455"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="457"/>
<end position="461"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="466"/>
<end position="474"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="495"/>
<end position="505"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="511"/>
<end position="522"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="532"/>
<end position="534"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="536"/>
<end position="538"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="542"/>
<end position="554"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="556"/>
<end position="564"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="575"/>
<end position="583"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="610"/>
<end position="617"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3V4P"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3V4V"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000255"/>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00803"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10604475"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11533025"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15466886"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1730718"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18635536"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19064666"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19349973"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23125415"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25398877"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3033641"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8643114"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9488735"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<sequence length="1032" mass="114900" checksum="73EC1204DE78CD35" modified="2010-11-02" version="3" precursor="true">MAWEARREPGPRRAAVRETVMLLLCLGVPTGRPYNVDTESALLYQGPHNTLFGYSVVLHSHGANRWLLVGAPTANWLANASVINPGAIYRCRIGKNPGQTCEQLQLGSPNGEPCGKTCLEERDNQWLGVTLSRQPGENGSIVTCGHRWKNIFYIKNENKLPTGGCYGVPPDLRTELSKRIAPCYQDYVKKFGENFASCQAGISSFYTKDLIVMGAPGSSYWTGSLFVYNITTNKYKAFLDKQNQVKFGSYLGYSVGAGHFRSQHTTEVVGGAPQHEQIGKAYIFSIDEKELNILHEMKGKKLGSYFGASVCAVDLNADGFSDLLVGAPMQSTIREEGRVFVYINSGSGAVMNAMETNLVGSDKYAARFGESIVNLGDIDNDGFEDVAIGAPQEDDLQGAIYIYNGRADGISSTFSQRIEGLQISKSLSMFGQSISGQIDADNNGYVDVAVGAFRSDSAVLLRTRPVVIVDASLSHPESVNRTKFDCVENGWPSVCIDLTLCFSYKGKEVPGYIVLFYNMSLDVNRKAESPPRFYFSSNGTSDVITGSIQVSSREANCRTHQAFMRKDVRDILTPIQIEAAYHLGPHVISKRSTEEFPPLQPILQQKKEKDIMKKTINFARFCAHENCSADLQVSAKIGFLKPHENKTYLAVGSMKTLMLNVSLFNAGDDAYETTLHVKLPVGLYFIKILELEEKQINCEVTDNSGVVQLDCSIGYIYVDHLSRIDISFLLDVSSLSRAEEDLSITVHATCENEEEMDNLKHSRVTVAIPLKYEVKLTVHGFVNPTSFVYGSNDENEPETCMVEKMNLTFHVINTGNSMAPNVSVEIMVPNSFSPQTDKLFNILDVQTTTGECHFENYQRVCALEQQKSAMQTLKGIVRFLSKTDKRLLYCIKADPHCLNFLCNFGKMESGKEASVHIQLEGRPSILEMDETSALKFEIRATGFPEPNPRVIELNKDENVAHVLLEGLHHQRPKRYFTIVIISSSLLLGLIVLLLISYVMWKAGFFKRQYKSILQEENRRDSWSYINSKSNDD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

